Public Health

  Posted on: Thursday, July 25, 2019
Epigenetic Tool for Detecting Exposure to WMD
Homeland Security News Wire
With a $38.8 million award from DARPA, researchers are working on developing a field-deployable, point-of-care device that will determine in 30 minutes or less whether a person has been exposed to weapons of mass destruction or their precursors. The device will be capable of detecting the health effects of a number of substances associated with weapons of mass destruction, including biological agents, radiation, chemicals and explosives. The detection devices will scan potential exposure victims for epigenetic changes, that is, chemical modifications that affect genes, altering their expression while leaving the genetic code intact.

Read the Full Story
 
Public Health:
11/16/19   FEMA's CDP Trains Responders, Hospital Staff to Protect Themselves from Deadly Diseases
11/15/19   Mosquito Sterilization Offers New Opportunity to Control Chikungunya, Dengue, and Zika
11/14/19   Lung injury cases now at 2,172, CDC says
11/14/19   More People in the United States Dying from Antibiotic-Resistant Infections Than Previously Estimated
11/14/19   Phase 3 trial shows MVA vaccine likely protects against smallpox
11/12/19   Typhoid: Neglect Outside Rich Countries Threatens New Global Health Emergency
11/11/19   Dams Across the U.S. Pose Potential Risk
11/11/19   European Commission grants final approval to Merck's Ebola vaccine
11/11/19   FBI, Partners Brief Pipeline Industry on National Security Threats to Energy Infrastructure
11/8/19   How Emergency Managers Can Meet Challenges of Increasingly Complex Threat Climate
11/8/19   Notes from the Field: Botulism Type E After Consumption of Salt-Cured Fish -- New Jersey, 2018
11/7/19   More than 2 million pounds of chicken products recalled in eight states
11/7/19   Salad Bars and Water Systems Are Easy Targets for Bioterrorists - and America's Monitoring System is Woefully Inadequate
11/1/19   Epidemiological Update - Measles
11/1/19   New Smallpox Vaccine Tested by USAMRIID Receives FDA Approval
10/26/19   Not a Single Country Prepared for Epidemic or Pandemic
10/25/19   More Ebola cases in DRC, including Butembo
10/24/19   U.S., South Korea Partner for Deeper Research on Emergency Preparedness, Pandemics
10/24/19   Vaping-related lung injuries rise to 1,604 cases nationwide, CDC says
10/23/19   BlueWillow Receives FDA Clearance to Begin Phase 1 Study of its Intranasal Anthrax Vaccine
Search Archives:



The St. Louis Fusion Center: Terrorism Early Warning Group is an information sharing initiative owned and operated by the  St. Louis Fusion Center. 
Should you have any questions please email info@sltew.org.

© 2019 St. Louis Fusion Center: Terrorism Early Warning Group. All rights reserved.